跳转至内容
Merck
CN

805122

PLGA微球

50 μm average diameter

别名:

Degradex® PLGA, PLGA Nanoparticles

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
(C3H4O2)x(C2H2O2)y
NACRES:
NA.23
UNSPSC Code:
12162002
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

powder

average diameter

50 μm

density

1.3 g/cm3

storage temp.

−20°C

General description

Degradex® is made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a Mw of 30,000.
To re-constitute:
  • Remove the product from freezer.
  • Wait until temperature rises to the ambient temperature.
  • Add DI water or buffer to the container.
  • Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.

Application

Plain PLGA particles for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.

Legal Information

Degradex is a registered trademark of Phosphorex, Inc.


Still not finding the right product?

Explore all of our products under PLGA微球


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

Biomaterials science integrates smart materials into biological research, requiring a deep understanding of biological systems.

Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.

Polymeric antioxidants show promise in drug delivery with superior bioavailability and antioxidant potential.





全球贸易项目编号

货号GTIN
805122-50MG04061832979830